Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation

Molecular and Cellular Biochemistry

Volumn 254, Issue 1-2, 2003, Pages 21-36

  Ranganna, Kasturi ^a   Yousefipour, Zivar ^a   Yatsu, Frank M ^b   Milton, Shirlette G ^a   Hayes, Barbara E ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Butyrate; Gene arrays; Proliferation; Smooth muscle cell

Indexed keywords

BUTYRIC ACID; CELL CYCLE PROTEIN; CLUSTERIN; COMPLEMENTARY DNA; CYCLIN B1; CYCLIN D1; CYCLINE; CYTOCHROME P450; DNA BINDING PROTEIN; GENE PRODUCT; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN; PROTEIN P130; PROTEIN P14; PROTEIN P15; PROTEIN P21; PROTEIN P55; RETINOBLASTOMA PROTEIN;

ANGIOPLASTY; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; DOWN REGULATION; DRUG EXPOSURE; DRUG MECHANISM; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE NUMBER; GENETIC ANALYSIS; GENETIC CODE; GROWTH INHIBITION; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLATING MEDIUM; PROTEIN FAMILY; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; RESTENOSIS; SEQUENCE HOMOLOGY; SMOOTH MUSCLE FIBER; STRESS; UNINDEXED SEQUENCE; UPREGULATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BLOTTING, NORTHERN; BUTYRATES; BUTYRIC ACID; CELL DIVISION; CELLS, CULTURED; DNA; DNA, COMPLEMENTARY; DOWN-REGULATION; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; MUSCLE, SMOOTH, VASCULAR; NEURONS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

ANIMALIA; EUKARYOTA;

EID: 0344897251     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027383710582     Document Type: Article

References (63)

1. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature 362: 801-809, 1993
2. Schwartz SM, deBlois D, O'Brien ERM: The intima: Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995
3. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253: 1129-1132, 1991
4. Pastore CJ, Isner JM, Bacha PA, Kearney M, Pickering JG: Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo. Results of local versus systemic administration. Circ Res 77: 519-529, 1995
5. Simons M, Edelman ER. Rosenberg RD: Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest 93: 2351-2356, 1994
6. The Multicenter European Research Trial with Cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (Mercator) study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circ 86: 100-110, 1992
7. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ: Inhibition of rat arterial cell proliferation by heparin. In vivo studies with anticoagulant and non-anticoagulant heparin. Circ Res 46: 625-634, 1980
8. Ranganna K, Joshi T, Yatsu FM: Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells. Atheroscler Thromb Vase Biol 15: 2273-2283, 1995
9. Ranganna K, Yatsu FM: Inhibition of platelet-derived growth factor-BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells. Arterioscler Thromb Vase Biol 17: 3420-3427, 1997
10. Ranganna K, Yatsu FM, Hayes BE, Milton SG, Jayakumar A: Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells. Mol Cell Biochem 205: 149-161, 2000
11. Cummings JH, Pomare EW, Branch WJ, Naylor CPE, MacFariane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227, 1987
12. Smith JG, German JB: Molecular and genetic effects of dietary derived butyric acid. Food Technol 49: 87-90, 1995
13. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H: Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterol 103: 51-56, 1992
14. Velazquez OC, Rombeau JL: Butyrate. Potential role in colon cancer prevention and treatment. Adv Exp Med Biol 427: 169-181, 1997
15. Kanauchi O, Iwanaga T, Mitsuyama K, Saiki T, Tsuruta O, Noguchi K, Toyonaga A: Pathophysiology of colonic mucosa, colitis and colon duplication. Butyrate from bacterial fermentation of germinated barley foodstuff preserves intestinal barrier function in experimental colitis in the rat model. J Gastroenterol Hepatol 14: 880-888, 1999
16. Wachtershauser A, Stein J: Rationale for the luminal provision of butyrate in intestinal disease. Eur J Nutr 39: 164-171, 2000
17. Prasad KN: Butyric acid: A small fatty acid with diverse biological functions. Life Sci 27: 1351-1358, 1980
18. Kruh J: Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biol 42: 65-82, 1982
19. Hague A, Butt AJ, Paraskeva C: The role of butyrate in human colonic epithelial cells: An energy source or inducer of differentiation and apoptosis? Proc Nutr Soc 55: 937-943, 1996
20. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C: Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway. Implications for the possible role of dietary fiber in the prevention of large-bowel cancer. Int J Cancer 55: 498-505, 1993
21. Hassig CA, Tong JK, Schreiber SL: Fiber-derived butyrate and the prevention of colon cancer. Chem Biol 4: 783-789, 1997
22. Avivi-Green C, Polak-Charcon S, Madar Z, Schwartz: Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: Correlation with colon cancer inhibition. Oncol Res 12: 83-95, 2000
23. Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, Lipkin M: Modulation of colonic epithelial cell proliferation, histone acetylation and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52: 5906-5912, 1992
24. Csordas A: On the biological role of histone acetylation. Biochem J 265: 23-38, 1990
25. Kruh J, Tichonicky L, Defer N: Effect of butyrate on gene expression. In: H.J. Binder, J.H. Cummings, K. Soergel (eds). Short Chain Fatty Acids. Kluwer, Dordrecht, 1994, pp 135-147
26. Feng P, Ge L, Akyhani N, Liau G: Sodium butyrate is a potent modulator of smooth muscle cell proliferation and gene expression. Cell Prolif 29: 231-241, 1996
27. Papadopoulos V, Kapsis A, Li H, Amri H, Hardwick M, Culty M, Kasprzyk PG, Carlson M, Moreau J-P, Drieu K: Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells. Anticancer Res 20: 2835-2848, 2000
28. Liang C-P, Tall AR: Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile add synthesis and transport with reversal by leptin treatment in Ob/ob mouse liver. J Biol Chem 276: 49066-49076, 2001
29. Gross C, Kelleher M, Iyer VR, Brown PO, Winge DR: Identification of the copper regulation in Saccharomyces cerevisiae by DNA microarrays. J Biol Chem 275: 32310-32316, 2000
30. Pietiainen V, Huttunen P, Hyypia T: Effects of echovirus 1 infection on cellular gene expression. Virol 276: 243-250, 2000
31. Eckmann L, Smith JR, Housley MP, Dwinell MB, Kagnoff MF: Analysis by high density cDNA arrays of altered gene expression in human intestinal epithelial cells in response to infection with the invasive enteric bacteria salmonella. J Biol Chem 275: 14084-14094, 2000
32. Hu D, Cao K, Peterson-Wakeman R, Wang R. Altered profile of gene expression in rat hearts induced by chronic nicotine consumption. Biochem Biophys Res Commun 297: 729-736, 2002
33. Mayanil CSK, George D, Freilich L, Miljan EL Mania-Farnell B, McLone DG, Bremer EG: Microarray analysis detects novel pax3 downstream target genes. J Biol Chem 276: 49299-49309, 2001
34. Kelman Z: PCNA: Structure, functions and interactions. Oncogene 14: 629-640, 1997
35. Hunter T, Pines J: Cyclins and cancer II Cyclin D and cdk inhibitors come of age. Cell 79: 573-582, 1994
36. Peter M, Herskowitz I: Joining the complex: Cyclin-dependent kinase inhibitory proteins and cell cycle. Cell 79: 181-184, 1994
37. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, EI-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396, 1994
38. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H, Sakai T: Butyrate activates the WAF1/Cip1 Gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 272: 22199-22206, 1997
39. Harper, JW, Elledge SJ, Keyomarsi K, Dynlacht B, Bai L-H, Zhang P, Dobrowoski S, Bai C, Connell-Growley L, Swindell E, Fox MP, Wei N: Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400, 1995
40. Luo Y, Hurwitz J, Massague J: Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159-161, 1995
41. Bravo R: Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 163: 287-293, 1986
42. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J 11: 961-971, 1992
43. Yan G-Z, Ziff EB: NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J Neurosci 15: 6200-6212, 1995
44. Weinstein J: Cell cycle-regulated expression, phosphorylation, and degradation of p55cdc. J Biol Chem 272: 28501-28511, 1997
45. Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R: Genetic approaches in mice to understand rel/NF-kappaB and IkappaB function: Transgenics and knockouts. Oncogene 18: 6888-6895, 1999
46. Miyamoto S, Seufzer BJ, Shumway SD: Novel IκBa proteolytic pathway in WEHI231 immature B cells. Mol Cell Biol 18: 19-29, 1998
47. Yin L, Laevsky G, Giardina C: Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J Biol Chem 276: 44641-44646, 2001
48. Rihn BH, Mohr S, McDowell SA, Binet S, Loubinoux J, Galateau F, Keith G, Leikauf GD: Differential gene expression in mesothelioma. FEBS Lett 480: 95-100, 2000
49. Fukada T, Yoshida Y, Nishida K, Obtani T, Shirogane T, Hibi M, Hirano T: Signaling through Gp130: Toward a general scenario of cytokine action. Growth Factors 17: 81-91, 1999
50. Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C, Sevignani C, Calabretta B, Sala A: Direct transactivation of the anti-apoptotic gene apolipoprotein J (Clusterin) by b-myb. J Biol Chem 275: 21055-21060, 2000
51. Imaizumi K, Morihara T, Mori Y, Katayamma T, Tsuda M, Furuyama T, Wanaka A, Takeda M, Tohyama M: The cell death-promoting gene DP5, which interacts with the bcl2 family, is induced during neuronal apoptosis following exposure to amyloid β protein. J Biol Chem 274: 7975-7981, 1999
52. Benjamin IJ, McMillan DR: Stress (heat shock) proteins. Molecular chaperones in cardiovascular biology and disease. Circ Res 83: 117-132, 1998
53. Liao D-F, Jin Z-G, Baas AS, Daum G, Gygi SP, Aebersold R, Berk BC: Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 275: 189-196, 2000
54. Hedges JC, Dechert MA, Yamboliev IA, Martin JL. Hickey E, Webers LA, Gerthofferm WT: A role for p38MAPK/HSP27 pathway in smooth muscle cell migration. J Biol Chem 274: 24211-24219, 1999
55. Patton WF, Erdjument-Bromage H, Marks AR, Tempst P, Taubman MB: Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyper-plastic agents. J Biol Chem 270: 21404-21410, 1995
56. Madamanchi NR, Li S, Patterson C, Runge MS: Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway. J Biol Chem 276: 18915-18924, 2001
57. Hayes JD, Pulford DJ: The glutathione s-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995
58. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearson ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ: Mitogenic signaling mediated by Oxidants in ras-transformed fibroblasts. Science 275: 1649-1652, 1997
59. Wang J, Boja ES, Tan W, Teklen E, Fales HM, English S, Mieyal JJ, Chock PB: Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276: 47763-47766, 2001
60. Ursini F, Maiorino M, Brigelius-Flohe R, Aumann KD, Roveri A, Schomburg D, Flohe L: Diversity of glutathione peroxidases. Meth Enzymol 252: 38-53, 1995
61. Kang Y-J, Enger MD: Glutathione content and growth in A549 human lung carcinoma cells. Expt Cell Res 187: 177-179, 1990
62. Kirby ML, Waldo KL: Neural crest and cardiovascular patterning. Circ Res 77: 211-215, 1995
63. Jain MK, Layne MD, Watanabe M, Chin MT, Feinberg MW, Sibinga NES, Hsieh C-M, Yet S-F, Stemple DL, Lee M-E: In vitro system for differentiating pluripotent neural crest cells into smooth muscle cells. J Biol Chem 273: 5993-5996, 1998